RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation, Cell Death Differ, vol.13, pp.1845-1856, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00146205
Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion, J Biol Chem, vol.283, pp.30549-30556, 2008. ,
Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase sensitizes human osteosarcoma cells to anticancer drugs, J Pharmacol Exp Ther, vol.325, pp.595-600, 2008. ,
CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis, J Bone Miner Res, vol.26, pp.1533-1542, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01129595
Metallothionein: the multipurpose protein, Cell Mol Life Sci, vol.59, pp.627-647, 2002. ,
The role of metallothionein in oxidative stress, Int J Mol Sci, vol.14, pp.6044-6066, 2013. ,
Human metallothionein expression under normal and pathological conditions: mechanisms of gene regulation based on in silico promoter analysis, Crit Rev Eukaryot Gene Exp, vol.19, pp.301-317, 2009. ,
A review of metallothionein isoforms and their role in pathophysiology, World J Surg Oncol, vol.9, p.54, 2011. ,
The functional significance of brain metallothioneins, FASEB J, vol.10, pp.1129-1136, 1996. ,
Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging, J Biol Chem, vol.277, pp.32353-32359, 2002. ,
Control of zinc transfer between thionein, metallothionein, and zinc proteins, Proc Natl Acad Sci, vol.95, pp.3489-3494, 1998. ,
Thiolate ligands in metallothionein confer redox activity on zinc clusters, Proc Natl Acad Sci, vol.95, pp.3478-3482, 1998. ,
The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase, Proc Natl Acad Sci, vol.95, pp.3483-3488, 1998. ,
Role of metallothionein in cadmium traffic and toxicity in kidneys and other mammalian organs, Biometals, vol.23, pp.897-926, 2010. ,
Overexpression of metallothionein confers resistance to anticancer drugs, Science, vol.241, pp.1813-1815, 1988. ,
Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin, Cancer Res, vol.51, pp.3237-3242, 1991. ,
Expression pattern of cisplatin-induced metallothionein isoforms in squamous cell carcinoma, Anticancer Res, vol.23, pp.299-303, 2003. ,
Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein, Cancer Cell Int, vol.4, p.6, 2004. ,
Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome, Virchows Arch, vol.450, pp.279-285, 2007. ,
Serum metallothionein in newly diagnosed patients with childhood solid tumours, Acta Biochim Pol, vol.57, pp.561-566, 2010. ,
Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone, Br J Cancer, vol.103, pp.73-81, 2010. ,
Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNAdamaging chemotherapy, Cell Death Differ, vol.10, pp.477-484, 2003. ,
Heavy metal ions in normal physiology, toxic stress, and cytoprotection, Ann N Y Acad Sci, vol.1113, pp.159-172, 2007. ,
Metallothioneins and cancer, Curr Protein Pept Sci, vol.10, pp.360-375, 2009. ,
Decreases of metallothionein and aminopeptidase N in renal cancer tissues, J Biochem, vol.129, pp.253-258, 2001. ,
Metallothionein expression in hepatocellular carcinoma, World J Gastroenterol, vol.8, pp.650-653, 2002. ,
Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues, Mol Cancer, vol.7, p.7, 2008. ,
Role of nutritional zinc in the prevention of osteoporosis, Mol Cell Biochem, vol.338, pp.241-254, 2010. ,
Insight to physiology and pathology of zinc(II) ions and their actions in breast and prostate carcinoma, Curr Med Chem, vol.18, pp.5041-5051, 2011. ,
From amino acids to proteins as targets for metal-based drugs, Curr Drug Metab, vol.13, pp.306-320, 2012. ,
Metallothioneins and zinc in cancer diagnosis and therapy, Drug Metab Rev, vol.44, pp.287-301, 2012. ,
Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metals, Eur J Clin Pharmacol, vol.53, pp.65-69, 1997. ,
Effects of statins on oxidative stress, Biol Trace Elem Res, vol.98, pp.119-127, 2004. ,
Effect of statin therapy on serum trace element status in dyslipidaemic subjects, J Trace Elem Med Biol, vol.19, pp.61-67, 2005. ,
Modulation of genes involved in zinc homeostasis in old low-grade atherosclerotic patients under effects of HMG-CoA reductase inhibitors, Rejuvenation Res, vol.11, pp.287-291, 2008. ,
Role of zinc in cellular zinc trafficking and mineralization in a murine osteoblast-like cell line, J Nutr Biochem, vol.22, pp.172-178, 2011. ,
Zinc may increase bone formation through stimulating cell proliferation, alkaline phosphatase activity and collagen synthesis in osteoblastic MC3T3-E1 cells, Nutr Res Pract, vol.4, pp.356-361, 2010. ,
Role of metallothionein isoforms in bone formation processes in rat marrow mesenchymal stem cells in culture, Biol Trace Elem Res, vol.104, pp.57-70, 2005. ,
Metallothioneins and platinum(II) anti-tumor compounds, Curr Med Chem, vol.16, pp.522-537, 2009. ,
Cisplatin and DNA repair in cancer chemotherapy, Trends Biochem Sci, vol.20, pp.435-439, 1995. ,
Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin, Cancer Res, vol.48, pp.4503-4508, 1988. ,
Protein expression profiles indicative for drug resistance of non-small cell lung cancer, Br J Cancer, vol.87, pp.251-257, 2002. ,
Over-expression of metallothionein predicts chemoresistance in breast cancer, J Pathol, vol.217, pp.563-570, 2009. ,
Zinc differentially modulates DNA damage induced by anthracyclines in normal and cancer cells, Exp Oncol, vol.34, pp.327-331, 2012. ,
Surfing the p53 network, Nature, vol.408, pp.307-310, 2000. ,
Live or let die: the cell's response to p53, Nat Rev Cancer, vol.2, pp.594-604, 2002. ,
P53 and its molecular basis to chemoresistance in breast cancer, Expert Opin Ther Targets, vol.16, issue.1, pp.23-30, 2012. ,
Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response, Cancer Res, vol.58, pp.2335-2338, 1998. ,
Interaction of metallothionein with tumor suppressor p53 protein, FEBS Lett, vol.580, pp.1235-1238, 2006. ,
Studies of interaction of tumor suppressor p53 with apo-MT using surface plasmon resonance, Anal Bioanal Chem, vol.395, pp.2569-2575, 2009. ,
Metal ions as regulators of the conformation and function of the tumour suppressor protein p53: implications for carcinogenesis, Proc Nutr Soc, vol.58, pp.565-571, 1999. ,
Interaction of tumor suppressor p53 with DNA and proteins, Curr Pharm Biotechnol, vol.11, pp.122-127, 2010. ,
P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma, Br J Cancer, vol.78, pp.757-759, 1998. ,
Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties, Biochemistry, vol.34, pp.4740-4747, 1995. ,
FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression, FASEB J, vol.22, pp.3813-3822, 2008. ,
Bisphosphonates induce breast cancer cell death in vitro, J Bone Miner Res, vol.15, pp.2211-2221, 2000. ,
Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis, Clin Cancer Res, vol.15, pp.5082-5091, 2009. ,
Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement, Arch Pathol Lab Med, vol.101, pp.14-18, 1977. ,